Jefferies 2015 Microbiome Conference

by Osel | Dec 14, 2015 | events

Jefferies 2015 Microbiome Conference KT Moortgat, Ph.D., Interim CEO of Osel, Inc., presented at the Jefferies Microbiome Conference on December 16, 2015 in...

The effect of Clostridium butyricum MIYAIRI on the prevention of pouchitis and alteration of the microbiota profile in patients with ulcerative colitis.

by Osel | Oct 29, 2015 | CBM588 CLINICAL

Yasueda A, Mizushima T, Nezu R, Sumi R, Tanaka M, Nishimura J, Kai Y, Hirota M, Osawa H, Nakajima K, Mori M, Ito T.     Synopsis: A randomized, placebo-controlled study was performed on 17 patients with ulcerative colitis who had under gone ileal pouch anal...

Safety assessment of the Clostridium butyricum MIYAIRI 588® probiotic strain including evaluation of antimicrobial sensitivity and presence of Clostridium toxin genes in vitro and teratogenicity in vivo.

by Osel | Oct 5, 2015 | CBM588

Isa K, Oka K, Beauchamp N, Sato M, Wada K, Ohtani K, Nakanishi S, McCartney E, Tanaka M, Shimizu T, Kamiya S, Kruger C, Takahashi M. Hum Exp Toxicol. 2015 Oct 5. pii: 0960327115607372. [Epub ahead of print]     Synopsis: Development of new live...

Smad2 and Smad3 Inversely Regulate TGF-β Autoinduction in Clostridium butyricum-Activated Dendritic Cells.

by Osel | Jul 21, 2015 | CBM588

Kashiwagi I, Morita R, Schichita T, Komai K, Saeki K, Matsumoto M, Takeda K, Nomura M, Hayashi A, Kanai T, Yoshimura A. Immunity. 2015 Jul 21;43(1):65-79. doi: 10.1016/j.immuni.2015.06.010. Epub 2015 Jun 30.     Synopsis: Colonization with a mixture of...

A breakthrough in probiotics: Clostridium butyricum regulates gut homeostasis and anti-inflammatory response in inflammatory bowel disease.

by Osel | May 2, 2015 | CBM588

Kanai T, Mikami Y, Hayashi A. J Gastroenterol. 2015 Sep;50(9):928-39. doi: 10.1007/s00535-015-1084-x. Epub 2015 May 5.     Synopsis: Intestinal immune homeostasis is regulated by gut microbiota, including beneficial and pathogenic microorganisms. Imbalance...